Skip to main content
Funded Studies

Matthew Farrer, PhD

Professor at University of British Columbia (UBC)

Location: Vancouver Canada

Professor Farrer holds a Canada Excellence Research Chair in Medical Genetics position at UBC and has contributed many peer-reviewed publications on the LRRK2 gene. His team made several original discoveries relating to the gene, including pathogenic mutations genetically linked with Parkinson’s disease. His group reported the genetic linkage, penetrance and a common founder for LRRK2 G2019S, and postulated increased kinase activity as the underlying mechanism responsible for disease. Current research interests include population genetic analysis of LRRK2 variants, generation of highly specific LRRK2 antibodies and protein biochemistry, cell-based drug screening assays and informative pre-clinical models. Since cloning the gene, his team has provided the plasmid to >50 laboratories, without restriction, and BAC LRRK2 human wild-type and mutant transgenic pre-clinical models and/or tissue to many teams. Professor Farrer is currently involved in natural history, genetic and biomarker studies of LRRK2 patients, including neuroimaging, to perform future clinical trials.

Associated Grants

  • Alpha-synuclein and Cognitive Decline in Parkinson’s Disease


  • Global Estimates for the Role of LRRK2 Variation in Parkinson's Disease Susceptibility


  • Multi-tracer positron emission tomography (PET) functional imaging as a tool to assess the relevance of rodent LRRK2 models to the human neurochemical phenotype associated with LRRK2 mutations related Parkinsonism


  • Technology for Clinicogenetic Studies of LRRK2 G2019S in Tunisia


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.